Castrén & Snellman advised Finnish Industry Investment Ltd (Tesi) on the deal. TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, announces it has completed...
TILT Biotherapeutics’ €10 Million Financing Round
Applied Materials’ Acquisition of Picosun
Castrén & Snellman advised CapMan Growth Equity Fund on the deal. Hannes Snellman advised Applied Materials Inc. Roschier advised the shareholders of Picosun. Applied Materials, Inc. has...